Loading…
Lobbying Income
$3.1M
Filings
74
Unique Clients
8
Active Period
2012–2015
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1130
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1130
Medicare Access and CHIP Reauthorization Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2
Medicare Access and CHIP Reauthorization Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: S. 598
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
2015 · first_quarter · Client: DAVITA INC.
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Client expense: — · Firm income: $60,000
Matched citations: S. 598
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
2014 · fourth_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Client expense: — · Firm income: $60,000
Matched citations: HR 4814
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
2014 · fourth_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Client expense: — · Firm income: $60,000
Matched citations: HR 4814
Motorsports Fairness and Permanency Act
2014 · fourth_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4933
Motorsports Fairness and Permanency Act
2014 · fourth_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1826
Motorsports Fairness and Permanency Act
2014 · third_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4933
Motorsports Fairness and Permanency Act
2014 · third_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1826
Veterans Dialysis Pilot Program Review Act of 2014
2014 · third_quarter · Client: DAVITA INC.
H.R. 4486: Military Construction and Veterans Affairs, and Related Agencies Appropriations Act, 2015 - Provisions related to veteran dialysis facilities H.R. 3831: Veterans Dialysis Pilot Program Review Act of 2014 S. 1547: Veterans Dialysis Pilot Program Review Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3831
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
2014 · third_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Client expense: — · Firm income: $60,000
Matched citations: HR 4814
Veterans Dialysis Pilot Program Review Act of 2013
2014 · third_quarter · Client: DAVITA INC.
H.R. 4486: Military Construction and Veterans Affairs, and Related Agencies Appropriations Act, 2015 - Provisions related to veteran dialysis facilities H.R. 3831: Veterans Dialysis Pilot Program Review Act of 2014 S. 1547: Veterans Dialysis Pilot Program Review Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S. 1547
Motorsports Fairness and Permanency Act
2014 · second_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4933
Motorsports Fairness and Permanency Act
2014 · second_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1826
Protecting Access to Medicare Act of 2014
2014 · second_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2014 · second_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4302
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
2014 · second_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
Client expense: — · Firm income: $60,000
Matched citations: HR 4814
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
2014 · second_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014.
Client expense: — · Firm income: $60,000
Matched citations: HR 4814
Hospital Readmissions Program Accuracy and Accountability Act of 2014
2014 · second_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 2501
Motorsports Fairness and Permanency Act
2014 · first_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1826
Protecting Access to Medicare Act of 2014
2014 · first_quarter · Client: DAVITA INC.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4302
Motorsports Fairness and Permanency Act
2013 · fourth_quarter · Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING
Issue education related to the depreciation of motorsports entertainment complex facilities and S.1826, the Motorsports Fairness and Permanency Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1826
Source: Senate LDA